Replies to post #149794 on Biotech Values

[poorgradstudent]

Chart had been telling the "story" on this for past few weeks; so did the very bearish options print.

Just so I'm clear, are these the same charts that were telling investors PPHM was an up and comer?

Are these the same charts that said ONXX's carfilzomib was doomed?

Are these also the same charts that said Tarceva was going to fail in NSCLC?


Let's not confuse fact and fiction, causation and subgroup correlation.